|Articles|March 30, 2020

COVID-19: Life in the time of coronavirus

Carl Awh, MD, explains offers insight on the changes his practice (Tennessee Retina in Nashville, Tennessee), has implemented for the sake of staff/patients' health, as well as the safety precautions he and his staff are taking on a daily basis amid the coronavirus pandemic.

See more coronavirus coverage

Don’t miss out—get OT Europe updates delivered straight to your inbox.

COVID-19: Life in the time of coronavirus

Related Content

AI's reach in retinal disease: Lab bench to bedside to backpack

Visual training may ease neuroadaptation to presbyopia-correcting IOLs

When to retest for inherited retinal dystrophies

Secondary IOL fixation: When to choose Yamane vs Gore-Tex

Effect of a maternal high-fat diet on the peripheral retina in mice

Latest CME

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

MacTel Decoded: Rethinking Conventional Approaches With Novel Neuroprotective Strategies

Treatment Optimization in the Evolving Anti-VEGF Era

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

(COPE) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(COPE Track) Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management

(CME Track) Cutting-Edge Care in Neovascular Retinal Disease: Expert Approaches to Selection and Interval Extension

(COPE Track) Next-Generation Solutions for nAMD and DME: Bridging Evidence and Practice Gaps in Disease Management

(COPE Track) Emerging Therapeutic Advancements in Dry Eye Disease Management

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

Think outside the cone: Applying the Gulani Keratoconus Classification